Alzinova (ALZ)

Last close As at 27/10/2025

SEK1.66

0.34 (25.30%)

Market capitalisation

SEK139m

Alzinova is a Swedish biopharmaceutical company in clinical development specializing in the treatment of Alzheimer’s disease.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Tord Labuda

    CEO

  • Erik Kullgren

    CFO

Thematics